David Magnesen, DPM
Podiatrist · St George, UTNPI 1699779066
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $497 of the $744 with a category attached, or 66.7%. Curonix LLC accounts for 66.7% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $515, more than ten times the $24 reported in 2019. That places this record below the midpoint for podiatrist clinicians in UT, where the typical reported total is $963.
Across 19 payments — averaging $39.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Curonix LLC$497
- AbbVie$54
- KCI USA, Inc.$27
- Nevro Corp.$27
- Organogenesis Inc.$27
- Tactile Systems Technology Inc$23
- plus $89 from 6 others
What the payments were for
- Travel & lodging$49767%
- Food & beverage$24833%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Curonix LLC | 2 | $497 |
| AbbVie | 3 | $54 |
| KCI USA, Inc. | 2 | $27 |
| Nevro Corp. | 2 | $27 |
| Organogenesis Inc. | 2 | $27 |
| Tactile Systems Technology Inc | 2 | $23 |
| Treace Medical Concepts, Inc. | 1 | $19 |
| Abbott | 1 | $18 |
| Orthofix Medical, Inc. | 1 | $15 |
| Smith+Nephew | 1 | $13 |
| Merck | 1 | $13 |
| Arthrosurface Incorporated | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$744 in reported general payments places this provider in the 45th percentile of 59 podiatrist providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 35 | $361 |
| Gabapentin | 31 | $202 |
| Duloxetine Hcl | 11 | $190 |
| Doxycycline Hyclate | 13 | $114 |
| Cephalexin | 14 | $104 |
| Pregabalin | 12 | $88 |
| Venlafaxine Hcl | 12 | $70 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in St George
- Andrew EvansSt George$6K
- Steven BaileySt George$1K
- Don YatesSt George$362
- Jeffrey StewartSt George$310
- Jason BruseLayton$203K
- Anna HronekSalt Lake City$82K
- Michele CarrDraper$56K
- David GraffOgden$39K
- Clark LarsenMurray$16K
- Kelly HamblinWest Jordan$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.